FDA approves new use for Roche's Avastin in colon cancer treatment
(Reuters) - The U.S. Food and Drug Administration on Wednesday approved the use of Roche's Avastin for patients whose colorectal cancer has worsened despite previous treatment with the drug.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news
More News: Avastin | Cancer | Cancer & Oncology | Colon Cancer | Colorectal Cancer | Food and Drug Administration (FDA) | Health